J Clin Microbiol 2010,48(3):900–907.PubMedCrossRef 10. Clarridge JE: Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious
diseases. Clin Microbiol Rev 2004,17(4):840–862.PubMedCrossRef 11. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY: Then and now: Use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008,14(10):908–934.PubMedCrossRef 12. von Graevenitz A, Funke G: An identification scheme for rapidly and aerobically growing gram-positive rods. Zentralbl Bakteriol 1996,284(2–3):246–254.PubMedCrossRef 13. Weyant RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, Daneshvar MI: Identification of unusual pathogenic Gram-negative aerobic and facultatively anaerobic bacteria. 2nd edition. Baltimore: selleck compound Williams & Wilkins; 1996. 14. Bosshard PP, Abels S, Altwegg M, Böttger EC, Zbinden R: Comparison of conventional and molecular methods for identification of aerobic catalase-negative Gram-positive cocci in the clinical laboratory. J Clin Microbiol 2004,42(5):2065–2073.PubMedCrossRef 15. Bosshard PP, Abels S, Zbinden R, Böttger EC, Altwegg M: Ribosomal
DNA sequencing for identification of aerobic Gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol 2003,41(9):4134–4140.PubMedCrossRef learn more 16. Bosshard PP, Zbinden R, Abels S, Böddinghaus B, Altwegg M, Böttger EC: 16S rRNA gene sequencing versus the API 20 NE system and the Vitek 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 2006,44(4):1359–1366.PubMedCrossRef 17. CLSI: Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline (MM18-A). Wayne, PA: Clinical and Laboratory Standards Institute; 2008. 18. Elias J, Frosch M, Vogel U: Neisseria . In Manual of Clinical Microbiology. Volume 1. 10th edition. Edited by: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Washington DC: ASM press; 2011:559–573. 19. Kämpfer P, Vaneechoutte
M, Lodders N, De Baere T, Avesani V, Janssens Isotretinoin M, Busse HJ, Wauters G: Description of selleck inhibitor Chryseobacterium anthropi sp. nov. to accommodate clinical isolates biochemically similar to Kaistella koreensis and Chryseobacterium haifense , proposal to reclassify Kaistella koreensis as Chryseobacterium koreense comb. nov. and emended description of the genus Chryseobacterium . Int J Syst Evol Microbiol 2009, 59:2421–2428.PubMedCrossRef 20. Vaneechoutte M, Dijkshoorn L, Nemec A, Kämpfer P, Wauters G: Acinetobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In Manual of Clinical Microbiology. Volume 1. 10th edition. Edited by: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Washington DC: ASM press; 2011:714–738. 21.